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The Millennium Development Goals have galvanized efforts to improve child survival (MDG-4) and maternal health
(MDG-5). There has been important progress on both MDGs at global level, although it now appears that few
countries will reach them by the target date of 2015. There are known and efficacious interventions to address
most of the major causes of these deaths, but important gaps remain. The biggest challenge is to ensure that all
women and children have access to life-saving interventions. Current levels of intervention coverage are too low,
representing missed opportunities. Providing services at the community level is an important emerging priority, but
preventing maternal and neonatal deaths also requires access to health facilities. Readers of the Medicine for Global
Health collectiona in BMC Medicine are urged to make maternal and child health one of their key concerns, even if
they work on other topics.
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The eight Millennium Development Goals (MDGs) arose
out of the United Nations Millennium Declaration of
2000, and set targets for levels of achievement for the
period from 1990 to 2015 [1]. MDG-4, “Reduce child mor-
tality”, has a target of reducing the under-five mortality
rate by two-thirds. MDG-5, “Improve maternal health”,
has a target of reducing the maternal mortality ratio by
three-quarters. Despite important limitations [2], the
MDGs have galvanized and focused global attention and
monitoring. MDGs 4 and 5 are important for global health
as a whole, because they represent the mortality endpoints
for women and children across specific diseases, nutri-
tional and environmental risk factors, and more distal de-
terminants including inequalities in economic resources
and education. Under-five mortality is also one of the
major determinants of life expectancy across the globe. In
this brief commentary, we review progress regarding
MDG-4 and MDG-5 in the 75 low- and middle-income
countries (LMIC) that account for over 95% of maternal
and child deaths [3].* Correspondence: jbrycedanby@aol.com
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health
Progress on MDG-4 for child survival has been impres-
sive at the global level, although it now appears clear
that the global target will not be reached [4]. The num-
ber of deaths among children under five worldwide has
decreased from 12.4 million [1] in 1990 to 7.6 million in
2010 [5], a reduction of nearly 40% in spite of an in-
crease in the number of births. Child deaths continue to
be concentrated in LMICs, and increasingly in sub-
Saharan Africa and South Asia [5]. Pneumonia, diarrhea
and malaria together accounted for over 30% of under-
five deaths in 2010, with three-quarters of deaths due to
major infections occurring in the first two years of life
[6]. Under-nutrition contributes to nearly half of all child
deaths [7]. As deaths in the 1- to 59-month age group
decline, deaths in the first 28 days (neonatal deaths) rep-
resent a growing proportion of all under-five deaths.
The major causes of neonatal deaths in 2010 were pre-
term birth complications, intrapartum complications
and pneumonia/sepsis [5].
Progress on MDG-5 for maternal health has been
slower than for MDG-4, with deaths declining from
around 400,000 to around 275,000 [8,9]. The major causes
of maternal deaths in 2010 are estimated to have beentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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tion (14.6%), sepsis (8.6%), and other direct and indirect
causes (35.5%) [10].
What interventions are available, and where are the gaps?
There has been important progress in identifying inter-
ventions to reduce mortality from the major causes of
child deaths, but gaps remain. For pneumonia, the newly-
implemented vaccine for pneumococcal disease holds
potential for sizable impact, but fails to protect against
prevalent serotypes in some LMICs [11]. Antibiotic treat-
ment of bacterial pneumonia is highly efficacious, but may
be compromised by increasing resistance of bacteria to
inexpensive antibiotics [12]. There is no available treat-
ment or vaccines for important viral causes of lower re-
spiratory illness, such as Respiratory Syncytial Virus. For
diarrhea, rotavirus is the most important cause of severe
childhood diarrhea globally, but the vaccine that is cur-
rently implemented appears to provide only about
50% protection in low-income countries [6]. Oral re-
hydration salts (ORS) solution and zinc are effective
treatments, but coverage remains too low [3]. For
malaria, early results suggest that the currently avail-
able vaccine may offer only modest protection of
young children in highly endemic areas [13,14]. Long-
lasting insecticide-treated nets that extend the period
of protection from 6 to 12 months to three years or
longer have been scaled up in the majority of coun-
tries where Plasmodium falciparum is a major cause
of child deaths, but the duration of protection varies
by product and remains under investigation [15,16].
Moreover, resistance to anti-malarial drugs is emerging
[13,17]. One important advance is the development andFigure 1 Intervention coverage and service contacts along the continuum
countries based on the most recent measurement since 2006 (%). Source: Adap
Survival, 2012.scaling up of rapid diagnostic tests to allow better
targeting of treatment for both malaria and pneumonia.
Preventing neonatal and maternal deaths is challenging,
especially where access to health facilities is limited.
Chlorhexidine, which is an antiseptic and disinfectant
agent, applied to the umbilical cord at birth reduces
deaths related to neonatal infection and is ready for imple-
mentation [18]. However, preventing intrapartum compli-
cations, such as obstructed labor and hemorrhage, two
leading causes of maternal deaths, managing babies that
are born very early, and treating neonatal sepsis, all re-
quire good practices at the time of labor and delivery and
preferably access to health facilities.
Achieving and sustaining high and equitable coverage
The real challenge in preventing unnecessary deaths
among women and children is ensuring that high-impact
interventions are available on demand and used by every
woman and child who needs them. Figure 1 shows the lat-
est available median coverage rates for a selection of inter-
ventions and service contacts across the continuum of
care from reproductive through maternal, neonatal and
child health tracked by Countdown to 2015 for Maternal,
Newborn and Child Survival [3]. With the exception of
vaccines and vitamin A supplementation, all interventions
are being severely under-utilized. Coverage is high for some
service contacts (for example, antenatal care), but little is
known about whether these opportunities to deliver inter-
ventions are actually being used [19]. New strategies for de-
livering interventions at the community level and ensuring
the continuous availability of essential commodities are
being adopted and implemented by countries, but not fast
enough. Within-country inequalities are also important. Inof care. Median national coverage of interventions in Countdown
ted from Countdown to 2015 for Maternal, Newborn and Child
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lower among the poorest families.
The reasons why few Governments in low-income
countries have been able to achieve high, sustained and
equitable coverage for interventions proven to reduce
maternal and child deaths vary by setting and are not
fully understood. Certainly resources - both foreign aid
and domestic investments - are a limiting factor [20,21],
as are competing global priorities that do not always
focus on the major causes of death. Rapid gains in cover-
age for insecticide-treated nets for malaria prevention
and complex interventions to reduce maternal-to-child
transmission of HIV demonstrate what can be done
given adequate political will and external financing [22].
Conflict and limited technical capacity at country level
are also important impediments. However, the interplay
of these factors at national and sub-national levels in the
highest-burden countries needs further research, and
there is unlikely to be a “one-size-fits-all” solution.
Future directions and conclusions
The MDGs have focused efforts on reduction of mater-
nal and child mortality. In the post-2015 era, the health
of women and children must remain a priority, and the
MDG targets must be extended. Governments must be
empowered to address the major causes of mortality in
their context, but the lens should be expanded to in-
clude maternal morbidity, maternal and child nutrition,
and child development. Programs must have the capacity
to identify the women and children who are not being
reached, and to develop local solutions for ensuring that
even those disenfranchised by poverty, ethnicity, gender
or conflict have continuous access to services delivered
at levels of quality that ensure their effectiveness [23].
Researchers and practitioners, including all those who
follow the Medicine for Global Health collection, must
ensure that the health of women and children in LMICs
is properly addressed, whatever the specific focus of
their research. The biggest challenge ahead is to combat
complacency, and to recognize that the gains made to
date only increase our responsibility to ensure that no
woman, mother, baby or child dies unnecessarily.
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